Skip to content

Study · Not a test of the peptide alone · 2007

1 result

Improvement in reproductive parameters in hypogonadal female mice by regulated gene replacement therapy in the central nervous system.

Jeong KH, Bakowska JC, Song IO, Fu N, Breakefield XO, Kaiser UB

Gene therapy3 May 2007Cited by 7 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Kisspeptin-10 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Kisspeptin-10.

  1. 01AnimalNot a test of Kisspeptin-10 aloneAnimal study (in vivo)Efficacy outcome

    In hypogonadal mice given a GnRH gene vector, kisspeptin‑10 challenge raised plasma LH, which supported regulation of the introduced GnRH transgene.

    In plain wordsIn mice given a GnRH gene treatment, kisspeptin‑10 was used as a test and LH rose, which supported regulation of the new gene.

    Outcome
    IncreasePlasma LH after kisspeptin-10 in GnRH-vector-treated hpg mice
    Study

    mousen: not reported in source

    Hypogonadal (hpg) female mice
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Source sentences

    Summary
    Administration of kisspeptin-10 resulted in an increase in plasma luteinizing hormone levels, further supporting appropriate regulation of the introduced GnRH transgene.
    1 context sentence
    Summary · context
    Here we show an improvement in reproductive parameters of adult female homozygous hpg mice by direct infusion into the hypothalamic preoptic area (POA) of a herpes simplex virus (HSV)-based amplicon vector containing a 13.5 kb genomic fragment encoding the GnRH gene together with its cognate promote…

    In this study, Kisspeptin-10 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Kisspeptin-10.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.